Condition
Azithromycin
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
83%
5 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (1)
P 3 (1)
P 4 (4)
Trial Status
Completed3
Unknown2
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04481555Phase 4Completed
Eosinophil-guided Reduction of Inhaled Corticosteroids
NCT05132829Phase 4Unknown
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
NCT04371107Phase 3Suspended
Proactive Care of Ambulatory COVID19 Patients
NCT05596721Phase 4Unknown
Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma
NCT05118984Phase 4Completed
Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes
NCT04617626Not ApplicableCompleted
Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire
Showing all 6 trials